J. Theodore Phillips

10.7k total citations · 2 hit papers
99 papers, 7.5k citations indexed

About

J. Theodore Phillips is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, J. Theodore Phillips has authored 99 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Pathology and Forensic Medicine, 32 papers in Oncology and 13 papers in Neurology. Recurrent topics in J. Theodore Phillips's work include Multiple Sclerosis Research Studies (63 papers), Polyomavirus and related diseases (28 papers) and Peripheral Neuropathies and Disorders (12 papers). J. Theodore Phillips is often cited by papers focused on Multiple Sclerosis Research Studies (63 papers), Polyomavirus and related diseases (28 papers) and Peripheral Neuropathies and Disorders (12 papers). J. Theodore Phillips collaborates with scholars based in United States, Germany and United Kingdom. J. Theodore Phillips's co-authors include Eva Havrdová, Michael Hutchinson, David H. Miller, Fred Lublin, Paul O’Connor, Chris H. Polman, Frances Lynn, A Wajgt, Michael Panzara and Alfred Sandrock and has published in prestigious journals such as New England Journal of Medicine, Neurology and Annals of Neurology.

In The Last Decade

J. Theodore Phillips

94 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

2006 2.4k citations Eva Havrdová, Michael Hutchinson et al. profile →
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

2012 1.0k citations Robert J. Fox, J. Theodore Phillips et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Theodore Phillips United States	33	5.2k	2.5k	2.0k	1.7k	1.2k	99	7.5k
Hans-Peter Hartung Germany	42	5.2k 1.0×	1.7k 0.7×	2.7k 1.3×	1.9k 1.1×	1.5k 1.3×	83	7.6k
Jan Lycke Sweden	43	4.1k 0.8×	1.3k 0.5×	1.8k 0.9×	1.1k 0.7×	876 0.7×	148	6.3k
Finn Sellebjerg Denmark	54	6.0k 1.1×	2.5k 1.0×	2.5k 1.2×	3.4k 2.0×	1.7k 1.4×	315	10.3k
Sandra Vukusic France	46	6.9k 1.3×	1.1k 0.4×	3.4k 1.7×	1.4k 0.9×	1.9k 1.6×	170	9.2k
Jordi Río Spain	44	5.2k 1.0×	1.3k 0.5×	2.2k 1.1×	994 0.6×	1.9k 1.6×	140	6.6k
Florian Deisenhammer Austria	43	4.4k 0.8×	1.2k 0.5×	2.8k 1.4×	1.6k 1.0×	1.7k 1.4×	225	7.2k
Richard Nicholas United Kingdom	42	4.7k 0.9×	1.2k 0.5×	1.8k 0.9×	1.8k 1.0×	941 0.8×	178	8.0k
Óscar Fernández Spain	35	3.1k 0.6×	956 0.4×	1.2k 0.6×	1.1k 0.7×	960 0.8×	199	4.9k
Marianne T. Sweetser United States	31	2.2k 0.4×	1.2k 0.5×	727 0.4×	2.2k 1.3×	939 0.8×	76	6.2k
Ingo Kleiter Germany	35	3.2k 0.6×	615 0.2×	2.7k 1.3×	714 0.4×	1.0k 0.9×	121	5.0k

Countries citing papers authored by J. Theodore Phillips

Since Specialization

Citations

This map shows the geographic impact of J. Theodore Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Theodore Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Theodore Phillips more than expected).

Fields of papers citing papers by J. Theodore Phillips

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Theodore Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Theodore Phillips. The network helps show where J. Theodore Phillips may publish in the future.

Co-authorship network of co-authors of J. Theodore Phillips

This figure shows the co-authorship network connecting the top 25 collaborators of J. Theodore Phillips. A scholar is included among the top collaborators of J. Theodore Phillips based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Theodore Phillips. J. Theodore Phillips is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sloane, Jacob A., J. Theodore Phillips, Jonathan Calkwood, et al.. (2018). Delayed-release Dimethyl Fumarate Demonstrated No Difference in Clinical Outcomes Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Real-World EFFECT Study (P1.362). Neurology. 90(15_supplement). 2 indexed citations

Fox, Robert J., Andrew Chan, Ralf Gold, et al.. (2017). Absolute Lymphocyte Count in Patients with Relapsing-Remitting Multiple Sclerosis Treated with Delayed-release Dimethyl Fumarate: Considerations for Patient Management (P5.391). Neurology. 88(16_supplement). 1 indexed citations

Fernández, Óscar, Gavin Giovannoni, Robert J. Fox, et al.. (2017). Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM. Clinical Therapeutics. 39(8). 1671–1679. 23 indexed citations

Gold, Ralf, Gavin Giovannoni, J. Theodore Phillips, et al.. (2016). Longer-Term Follow-Up of the Efficacy of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis: Integrated Analysis of DEFINE, CONFIRM, and ENDORSE (P3.033). Neurology. 86(16_supplement). 1 indexed citations

Fox, Robert J., Andrew Chan, Ralf Gold, et al.. (2016). Characterization of Absolute Lymphocyte Count Profiles in MS Patients Treated with Delayed-Release Dimethyl Fumarate: Considerations for Patient Management (P2.099). Neurology. 86(16_supplement). 5 indexed citations

Phillips, J. Theodore, et al.. (2015). Results of a Delphi Panel to Address Management of Gastrointestinal Side Effects Observed with Use of Delayed-release Dimethyl Fumarate (P3.242). Neurology. 84(14_supplement). 3 indexed citations

Chan, Andrew, J. Theodore Phillips, Robert J. Fox, et al.. (2015). Differential Recovery from Relapse Between Treatment Groups in the CONFIRM Study of Delayed-Release Dimethyl Fumarate (P7.215). Neurology. 84(14_supplement). 1 indexed citations

Bar‐Or, Amit, Ralf Gold, Robert J. Fox, et al.. (2015). Five-Year Follow-up of Delayed-Release Dimethyl Fumarate in RRMS: Integrated Clinical Efficacy Data from the DEFINE, CONFIRM, and ENDORSE Studies (P7.234). Neurology. 84(14_supplement). 7 indexed citations

Pozzilli, Carlo, J. Theodore Phillips, Robert J. Fox, et al.. (2015). Long-term Follow-up of the Safety of Delayed-Release Dimethyl Fumarate in RRMS: Interim Results from the ENDORSE Extension Study. (P7.235). Neurology. 84(14_supplement). 5 indexed citations

10.

Phillips, J. Theodore, Ralf Gold, Gavin Giovannoni, et al.. (2015). Clinical Efficacy of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis Patients with Highly Active Disease: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies (P7.228). Neurology. 84(14_supplement). 2 indexed citations

11.

Kita, Mariko, Robert J. Fox, Ralf Gold, et al.. (2014). Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies. Clinical Therapeutics. 36(12). 1958–1971. 30 indexed citations

12.

Hutchinson, Michael, J. Theodore Phillips, D. H. Miller, et al.. (2013). Efficacy and Safety of BG-12 (Dimethyl Fumarate) in Relapsing-Remitting Multiple Sclerosis in the Phase 3 CONFIRM Study. UCL Discovery (University College London). 1 indexed citations

13.

Miller, D. H., J. Theodore Phillips, Michael Hutchinson, et al.. (2012). Effects of BG-12 on magnetic resonance imaging outcomes in CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis), a randomized, placebo-controlled, phase 3 study. UCL Discovery (University College London). 3 indexed citations

14.

Miller, D. H., et al.. (2012). Effect of BG-12 on magnetic resonance imaging activity in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study. UCL Discovery (University College London). 3 indexed citations

15.

Hutchinson, Michael, D. H. Miller, J. Theodore Phillips, et al.. (2012). Effect of BG-12 in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study. UCL Discovery (University College London). 2 indexed citations

16.

Havrdová, Eva, D. H. Miller, J. Theodore Phillips, et al.. (2012). Clinical and neuroimaging outcomes with BG-12 treatment in CONFIRM (comparator and an oral fumarate in relapsing-remitting multiple sclerosis), a multicenter, randomized, placebo-controlled, phase-3 study. UCL Discovery (University College London). 2 indexed citations

17.

Stüve, Olaf, Petra D. Cravens, Elliot M. Frohman, et al.. (2008). Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy. Neurology. 72(5). 396–401. 101 indexed citations

18.

Stüve, Olaf, Christina M. Marra, Amit Bar‐Or, et al.. (2006). Altered CD4+/CD8+ T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis. Archives of Neurology. 63(10). 1383–1383. 220 indexed citations

19.

Frohman, Elliot M., Massimo Filippi, Olaf Stüve, et al.. (2005). Characterizing the Mechanisms of Progression in Multiple Sclerosis. Archives of Neurology. 62(9). 1345–1345. 83 indexed citations

20.

Koh, Crystal Y. & J. Theodore Phillips. (1993). Prolactin receptor expression by lymphoid tissues in normal and immunized rats. Molecular and Cellular Endocrinology. 92(2). R21–R25. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact